Data / Form D filings / ACHILLION PHARMACEUTICALS INC
ACHILLION PHARMACEUTICALS INC: Form D filing
ACHILLION PHARMACEUTICALS INC, a pharmaceuticals company in New Haven, CT, filed a Form D with the SEC in 2010. The latest, on August 23, 2010, reports $50.1 million sold of a $50.1 million offering to 6 investors.
Find out what ACHILLION PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 GEORGE STREET, New Haven, CT, 06511
- Phone
- (203) 624-7000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1070336
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 23, 2010 | New notice | $50,105,162 | $50,105,162 | $0 | 6 | Aug 20, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary E. Frashier | Director | |
| Gautam S. Shah | Executive Officer | |
| Joseph S. Truitt | Executive Officer | |
| Elizabeth S. Olek | Executive Officer | |
| Robert L. Van Nostrand | Director | |
| David I. Scheer | Director | |
| Michael D. Kishbauch | Executive Officer, Director | |
| Michael E. Grey | Director | |
| Mary Kay S. Fenton | Executive Officer | |
| Nicholas J. Simon | Director | |
| Milind S. Deshpande | Executive Officer | |
| David P. Wright | Director | |
| Dennis C. Liotta | Director | |
| Jason S. Fisherman | Director |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Aug 23, 2010 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ACHILLION PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.